Search Within

Erel Joffe

Formats
  1. Meeting Abstract (55)
  2. Journal Article (23)
  3. Research Letter (3)
  4. Review (2)
Groups
  1. Department of Medicine (83)
  2. Hematologic Malignancies, Division of (83)
  3. Sloan Kettering Institute Postdocs (83)
  4. Survivorship Research (55)
  5. Center for Hematologic Malignancies (49)
  6. Lymphoma (48)

More Groups

People
  1. Andrew Zelenetz (45)
  2. Ariela Noy (40)
  3. Maria Palomba (40)
  4. Matthew Matasar (37)
  5. Anita Kumar (35)
  6. Connie Batlevi (35)

More People

Years
  1. 2024 (4)
  2. 2023 (9)
  3. 2022 (14)
  4. 2021 (22)
  5. 2020 (18)
  6. 2019 (13)

More Years

Publications
  1. Blood (30)
  2. Hematological Oncology (10)
  3. Journal of Clinical Oncology (9)
  4. Blood Advances (6)
  5. Blood Cancer Journal (4)
  6. International Journal of Radiation Oncology, Biology, Physics (3)

More Publications

Publishers
  1. American Society of Hematology (36)
  2. Wiley Blackwell (10)
  3. American Society of Clinical Oncology (9)
  4. Elsevier Inc. (8)
  5. Nature Publishing Group (5)
  6. Taylor & Francis Group (3)

More Publishers

Results (83)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RE-MIND2: Comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma
    Journal Article

    Nowakowski, G. S.; Yoon, D. H.; Mondello, P.; Joffe, E.; Peters, A.; Fleury, I.; Greil, R.; Ku, M.; Marks, R.; Kim, K.; more...
    Annals of Hematology (2023)

    Fulltext@MSK | Save
  • Predictors of survival in patients with MALT lymphoma: A retrospective, case-control study
    Review

    Qi, S.; Liu, X.; Noy, A.; Lee, J.; Teckie, S.; Hajj, C.; Joffe, E.; Imber, B. S.; Yahalom, J.
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with positive interim positron emission tomography (PET) continuing ABVD in the clinical setting
    Journal Article

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S.; Kumar, A.; Matasar, M. J.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • Ttafasitamab plus lenalidomide (TAFA+LEN) versus pola-BR, r2, and CAR-T in non-transplant eligible (NTE) relapsed/refractory (r/r) DLBCL: A post hoc analysis of the RE-MIND2 study comparing multiple cohort-balancing approaches
    Meeting Abstract

    CoĢrdoba, R.; Zinzani, P. L.; Joffe, E.; Yoon, D. H.; Peters, A.; Waltl, E. E.; Alvero, C.; Sabatelli, L.; Salles, G.; Nowakowski, G. S.
    Value in Health (2022)

    Fulltext@MSK | Save
  • Subgroup analysis in RE-MIND2: An observational, retrospective cohort study of tafasitamab + lenalidomide versus systemic therapies in patients with relapsed/refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Nowakowski, G.; Yoon, D. H.; Joffe, E.; Zinzani, P. L.; Sabatelli, L.; Waltl, E. E.; Alvero, C. G.; Hess, G.; Riedell, P.; Kim, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Genetic Alterations of CREBBP are associated with radiosensitivity in follicular lymphoma
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E. S.; Lee, J.; Fregonese, B.; Tringale, K. R.; Hubbeling, H.; Sarkar, R.; Ma, J.; Seshan, V.; Joffe, E.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • LymphGen classification of diffuse large B-cell lymphoma in a cohort of adolescent and young adult (AYA) patients
    Meeting Abstract

    Cabal, A.; Zhu, M.; Uppal, M.; Joffe, E.; Batlevi, C. L.; Matasar, M. J.; Okwali, M.; Dogan, A.; Zelenetz, A. D.; Salles, G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Preliminary safety and efficacy data on two patients with relapsed/refractory CNS lymphoma treated with emavusertib (CA-4948) and ibrutinib combination: A subset analysis of TakeAim Lymphoma trial
    Meeting Abstract

    Iqbal, M.; Tun, H.; Joffe, E.; Grommes, C.; Nowakowski, G.; Lunning, M.; Ramchandren, R.; Li, C. C.; Zhao, W.; Martinez, E.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: A phase II risk-adapted design
    Journal Article

    Kumar, A.; Casulo, C.; Joffe, E.; Moskowitz, C.; Gerecitano, J.; Moskowitz, A.; Younes, A.; Drullinsky, P.; Drill, E.; Choma, M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Subgroup analysis in RE-MIND2, an observational, retrospective cohort study of tafasitamab plus lenalidomide versus systemic therapies in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)
    Meeting Abstract

    Nowakowski, G. S.; Yoon, D. H.; Joffe, E.; Zinzani, P. L.; Sabatelli, L.; Waltl, E. E.; Alvero, C. G.; Hess, G.; Riedell, P. A.; Kim, K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save